Peddock Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Hold
755
0.05% 140
2026
Q1
$266K Hold
755
0.06% 134
2025
Q4
$247K Hold
755
0.05% 148
2025
Q3
$213K Hold
755
0.05% 157
2025
Q2
$211K Hold
755
0.05% 155
2025
Q1
$235K Buy
+755
New +$223K 0.06% 145
2024
Q4
Sell
-820
Closed -$264K 159
2024
Q3
$264K Buy
820
+87
+12% +$28.5K 0.06% 142
2024
Q2
$229K Hold
733
0.06% 147
2024
Q1
$208K Buy
+733
New +$214K 0.05% 153
2020
Q1
Sell
-70
Closed -$17K 111
2019
Q4
$17K Buy
+70
New +$15.4K 0.01% 204
2019
Q2
Sell
-69
Closed -$13K 118
2019
Q1
$13K Buy
69
+1
+1% +$191 0.01% 209
2018
Q4
$13K Hold
68
0.01% 211
2018
Q3
$14K Buy
68
+1
+1% +$197 0.01% 219
2018
Q2
$12K Hold
67
0.01% 221
2018
Q1
$11K Buy
67
+1
+2% +$184 0.01% 218
2017
Q4
$12K Hold
66
0.01% 218
2017
Q3
$12K Buy
66
+1
+2% +$177 0.01% 218
2017
Q2
$11K Hold
65
0.01% 223
2017
Q1
$11K Buy
65
+59
+983% +$9.8K 0.01% 199
2016
Q4
$1K Hold
6
﹤0.01% 216
2016
Q3
$1K Buy
+6
New +$1.01K ﹤0.01% 230

Other funds holding AMGN

Peddock Capital Advisors's AMGN Position: Q2 2026 in Review

Peddock Capital Advisors held its Amgen (AMGN) position steady in Q2 2026 at 755 shares worth $273K. The position accounts for 0.05% of the portfolio, ranked #140.

Peddock Capital Advisors first reported a position in AMGN in Q3 2016 and has held it in 21 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Peddock Capital Advisors held 755 shares of Amgen worth $273K as of Q2 2026.
  • Peddock Capital Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.05% of Peddock Capital Advisors's portfolio in Q2 2026, its #140 holding.
  • Peddock Capital Advisors first reported a position in Amgen in Q3 2016 and has held it in 21 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Peddock Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.